What is Another Name for Ivermectin in Australia? Do You Need a Prescription?

Ivermectin another name in Australia

They use Ivermectin worldwide to treat parasitic infections of the gastrointestinal tract, skin and eyes.

The following dosage forms are available:

  • Oral tablets;
  • Skin cream;
  • Skin lotion.

In Australia, you can also find Ivermectin under the brand name Stromectol.

Stromectol is approved for:

  • Onchocerciasis and intestinal strongyloidiasis (angillulosis);
  • Crusted scabies;
  • Sarcoptic scabies in humans.

Stromectol is only available in oral form. You can buy the medicine by prescription.

It is a subsidised drug. On August 1, 2022, Stromectol was confirmed to be available on PBS (Pharmaceutical Benefits Scheme).

You can buy the medicine under the brand names Ivermectin and Stromectol in Australia. There are no other names for Ivermectin In Australia.

Ivermectin is a brand name for humans

In different countries, you can buy Ivermectin under other brand names:

  • Sklice;
  • Soolantra;
  • Stromectol.

These Ivermectin trade names are for humans.

Generic name for Ivermectin for humans and animals

Since the medicine is for both humans and animals, the list of Ivermectin generic brand names is impressive enough:

  • Ivomec worldwide;
  • Heartgard, Sklice and Stromectol in the USA;
  • Mectizan in Canada and 45 countries of Africa, Latin America, the Middle East and Southeast Asia;
  • Ivexterm in Mexico;
  • Iver-DT in Nepal;
  • Scabo in 6 countries of Southeast Asia;
  • Soolantra worldwide only to treat rosacea.

Generics use the same active ingredient as the brand name drug. They are as safe and effective as the original medicine. And usually, they are cheaper than the brand name drug.


Apart from the branded drug under the trade name Ivermectin, there are many generics worldwide, some of which are only for humans and some for animals. The medicine (including generics) is available in tablets, cream and lotion.

Ivermectin is a trendy medication for treating parasitic infections in humans and animals. The drug’s developers won the Nobel Prize in Physiology or Medicine in 2015.